USPSTF Revises Recommendation Statement on Statin Use for the Primary Prevention of CVD
Two Data Errors Reported in 2016, Now Corrected
February 26, 2020
On Feb. 18, the U.S. Preventive Services Task Force (USPSTF) published a revised version of its 2016 final recommendation statement on Statin Use for the Primary Prevention of Cardiovascular Disease (CVD) in Adults.
In the Feb. 18 email to USPSTF Dissemination and Implementation Partners, USPSTF said, “after learning about two data errors in the evidence review on statins for the primary prevention of cardiovascular disease which affected the relative risk reduction for cardiovascular mortality in those taking statins, the USPSTF carefully reviewed the corrected data and the 2016 recommendation statement.”
The revised recommendation statement reflects the corrected data and can be found on the USPSTF website.
More resources
Statin Use for the Primary Prevention of CVD in Adults: Preventive Medication
PAs Counsel Patients on Heart Health
Thank you for reading AAPA’s News Central
You have 2 articles left this month. Create a free account to read more stories, or become a member for more access to exclusive benefits! Already have an account? Log in.